ORGANIZATION
PhRMA Sounds Alarm on “Huge Seller” Re-Pricing, Possible Decline in Japan Investment
Tony Alvarez, Japan chief of the Pharmaceutical Research and Manufacturers of America (PhRMA), on December 11 reiterated the industry’s demand for the upcoming drug pricing reform next April, warning that proposed anti-innovation measures would lead to a decline in the…
To read the full story
ORGANIZATION
- Boehringer’s Hasson Appointed EFPIA Japan Vice Chair
June 22, 2026
- Think Tank Opposes Cap on Social Security Burden Ratio, Urges Pause in Off-Year Price Cuts
June 22, 2026
- Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
June 18, 2026
- Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
June 15, 2026
- Raise Foreign Price Adjustment Cap for Listed Products in German Cases: FPMAJ
June 15, 2026
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…





